Cargando…
Unleashing the power of NK cells in anticancer immunotherapy
Due to their physiological role in removing damaged cells, natural killer (NK) cells represent ideal candidates for cellular immunotherapy in the treatment of cancer. Thereby, the cytotoxicity of NK cells is regulated by signals on both, the NK cells as well as the targeted tumor cells, and the inte...
Autores principales: | Vogler, Meike, Shanmugalingam, Senthan, Särchen, Vinzenz, Reindl, Lisa Marie, Grèze, Victoria, Buchinger, Leon, Kühn, Michael, Ullrich, Evelyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843917/ https://www.ncbi.nlm.nih.gov/pubmed/34374809 http://dx.doi.org/10.1007/s00109-021-02120-z |
Ejemplares similares
-
Characterization of BV6-Induced Sensitization to the NK Cell Killing of Pediatric Rhabdomyosarcoma Spheroids
por: Särchen, Vinzenz, et al.
Publicado: (2023) -
Pediatric multicellular tumor spheroid models illustrate a therapeutic potential by combining BH3 mimetics with Natural Killer (NK) cell-based immunotherapy
por: Särchen, Vinzenz, et al.
Publicado: (2022) -
Arming Immune Cells for Battle: A Brief Journey through the Advancements of T and NK Cell Immunotherapy
por: Wendel, Philipp, et al.
Publicado: (2021) -
Mitochondrial apoptosis: facilitator of NK cell-mediated immunotherapy
por: Ullrich, Evelyn, et al.
Publicado: (2022) -
P1354: CRISPR/CAS9 GENE EDITING OF IMMUNE CHECKPOINT RECEPTOR NKG2A IMPROVES THE ANTI-LEUKEMIC EFFICACY OF PRIMARY CD33-TARGETING CAR-NK CELLS.
por: Albinger, Nawid, et al.
Publicado: (2023)